Riskpilot← Back to searchSign inGet full accessTANGEN HELSEKLINIKK AS
ASActiveOrg 917039577Vestveien 51B, 1450 NesoddtangenOther human health activities n.e.c. · NACE 8699Est. 20160 employees
Revenue 2024
NOK 668K
+11% vs 2023
EBITDA margin
7.3%
+137% vs 2023
Equity ratio
54.9%
Financial strength
Net profit 2024
NOK 37K
+207% vs 2023
| Revenue | NOK 668K | +11% |
| EBITDA | NOK 49K | +137% |
| Net profit | NOK 37K | +207% |
| Total assets | NOK 302K | +2% |
| Equity | NOK 165K | +29% |
| Employees | 0 | — |
Legal name
TANGEN HELSEKLINIKK AS
Org number
917039577
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
18. april 2016
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Behandling og oppfølging av somatiske og psykiske lidelser, velvære, foredragsvirksomhet og andre helsetjenester, samt det som naturlig står i forbindelse med dette.
Address
Vestveien 51B, 1450 Nesoddtangen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 553 | 704 | 600 | 602 | 668 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 37 | 73 | −46 | 21 | 49 |
| Depreciation & amort. | −14 | −14 | −5 | −5 | −3 |
| EBIT | 23 | 58 | −51 | 15 | 46 |
| Net financials | 0 | 0 | 0 | 0 | 1 |
| Profit before tax | 23 | 58 | −51 | 15 | 47 |
| Tax | 5 | 13 | −11 | 3 | 10 |
| Net profit | 18 | 45 | −40 | 12 | 37 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 479 | 546 | 129 | 295 | 302 |
| Equity | 357 | 402 | 116 | 128 | 165 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 122 | 144 | 13 | 166 | 136 |
| Total debt | 122 | 144 | 13 | 166 | 136 |
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
20202024
Equity ratio
54.9%
This company
38.2%
Market median
+44% vs market
20202024
Return on equity
22.4%
This company
18.4%
Market median
+22% vs market
20202024
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20202024
Asset turnover
2.22×
This company
1.12×
Market median
+98% vs market
20202024
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Chairman | 2016 | |
| Board of Directors | 2016 | |
| Chairman | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 34% | 34% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TANGEN HELSEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tina Elise Haugland | Board of Directors | 0 companies |
| Helge Andreas Felberg | Chairman | 0 companies |
| Morten Markvard Christensen | Board of Directors | 0 companies |
| Thea Reynolds | Chairman | 0 companies |